Apomorphine Does Not Alter Amphetamine‐Induced Dopamine Release Measured in Striatal Dialysates
暂无分享,去创建一个
[1] K. Strait,et al. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase. , 1986, Molecular pharmacology.
[2] D. Segal,et al. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[3] R. Wilcox,et al. Prevention of amphetamine-induced behavioral hypersensitivity by concomitant treatment with microgram doses of apomorphine. , 1987, European journal of pharmacology.
[4] B. Westerink. Sequence and significance of dopamine metabolism in the rat brain , 1985, Neurochemistry International.
[5] D. Paton. Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria , 1973, British journal of pharmacology.
[6] M. Schwarzschild,et al. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. , 1989, Annual review of neuroscience.
[7] M. Blaustein,et al. Synaptic vesicle recycling in synaptosomes in vitro , 1976, Nature.
[8] R. Holz. The release of dopamine from synaptosomes from rat striatum by the ionophores X 537A and A 23187. , 1975, Biochimica et biophysica acta.
[9] J. V. van Ree,et al. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. , 1987, European journal of pharmacology.
[10] R. Roth,et al. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.
[11] R. Roth. CNS Dopamine Autoreceptors: Distribution, Pharmacology, and Function a , 1984, Annals of the New York Academy of Sciences.
[12] D. Segal,et al. Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. , 1987, The Journal of pharmacology and experimental therapeutics.
[13] B. Costall,et al. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei. , 1974, European journal of pharmacology.
[14] U. Ungerstedt,et al. Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. , 1986, European journal of pharmacology.
[15] K. E. Moore,et al. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. , 1973, The Journal of pharmacology and experimental therapeutics.
[16] I. Lucki,et al. Increased sensitivity to d-and l-amphetamine action after midbrain raphe lesions as measured by locomotor activity , 1979, Neuropharmacology.
[17] N. Swerdlow,et al. The neural substrates for the motor-activating properties of psychostimulants: A review of recent findings , 1986, Pharmacology Biochemistry and Behavior.
[18] B. Westerink,et al. Use of Calcium Antagonism for the Characterization of Drug‐Evoked Dopamine Release from the Brain of Conscious Rats Determined by Microdialysis , 1989, Journal of neurochemistry.
[19] B. Hamberger,et al. Drug-Induced Changes in the Release of 3H-Monoamines from Field Stimulated Rat Brain Slices , 1971 .
[20] J. C. Stoof,et al. Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system , 1975, Brain Research.
[21] G. Koob,et al. Effects of lesions of the ventral medial tegmentum on locomotor activity, biogenic amines and response to amphetamine in rats , 1980, Pharmacology Biochemistry and Behavior.
[22] S. Z. Langer,et al. Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine. , 1981, The Journal of pharmacology and experimental therapeutics.
[23] M. Raiteri,et al. Stimulus-coupled release of unmetabolized 3-H-norepinephrine from rat brain synaptosomes. , 1975, Pharmacological research communications.
[24] D. Segal. Differential effects of Para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy , 1976, Brain Research.
[25] S. Tenen,et al. Antiamphetamine effects following inhibition of tyrosine hydroxylase. , 1966, The Journal of pharmacology and experimental therapeutics.
[26] R. S. Sloviter,et al. Evidence that serotonin mediates some behavioral effects of amphetamine. , 1978, The Journal of pharmacology and experimental therapeutics.
[27] R. Kuczenski. Biphasic effects of amphetamine on striatal dopamine dynamics. , 1977, European journal of pharmacology.
[28] N. Uretsky,et al. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation. , 1982, The Journal of pharmacology and experimental therapeutics.
[29] A. Grace,et al. Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. , 1979, Science.
[30] H. Benveniste,et al. Determination of Brain Interstitial Concentrations by Microdialysis , 1989, Journal of neurochemistry.
[31] A. Carlsson,et al. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.
[32] C. Connor,et al. Evidence that amphetamine and Na+ gradient reversal increase striatal synaptosomal dopamine synthesis through carrier-mediated efflux of dopamine. , 1986, Biochemical pharmacology.
[33] K. E. Moore,et al. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. , 1975, The Journal of pharmacology and experimental therapeutics.
[34] M. Raiteri,et al. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. , 1979, The Journal of pharmacology and experimental therapeutics.
[35] L. Grant,et al. Selective potentiation of locomotor effects of amphetamine by midbrain raphé lesions. , 1972, Physiology & behavior.
[36] K. Starke. Regulation of noradrenaline release by presynaptic receptor systems. , 1977, Reviews of physiology, biochemistry and pharmacology.
[37] A. Cho,et al. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. , 1979, The Journal of pharmacology and experimental therapeutics.
[38] G. Di Chiara,et al. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. , 1988, The Journal of pharmacology and experimental therapeutics.
[39] S. Iversen,et al. Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats , 1976 .
[40] D. Segal,et al. Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine , 1989, Brain Research.
[41] G. Chiara,et al. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats , 1989, Neuroscience.
[42] T. Ljungberg,et al. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis , 1987, Brain Research.
[43] B. Campbell,et al. Serotonergic inhibition of catecholamine-induced behavioral arousal. , 1973, Brain research.
[44] A. D. Smith. MECHANISMS INVOLVED IN THE RELEASE OF NORADRENALINE FROM SYMPATHETIC NERVES , 1973 .